Respiratory Diseases
Respiratory diseases impose an immense worldwide health burden. Five of these diseases are among most common causes of severe illness and death worldwide.
- Chronic obstructive pulmonary disease (COPD)
- Asthma
- Acute lower respiratory tract infections
- Acute upper respiratory tract infections
65
Million people estimated to have moderate to severe COPD
334
Million people suffer from Asthma; the number is rising
$71
Billion to $167 billion are on treating respiratory tract infections annually
The facts are frightening.
- COPD causes 3 million deaths each year, making it the third leading cause of death worldwide – and the numbers are increasing.
- For decades, acute lower respiratory tract infections have been among the top three causes of death and disability among both children and adults.
- It is estimated that lower respiratory tract infection causes nearly 4 million deaths annually and is a leading cause of death among children under 5 years old.
- Acute lower respiratory tract infections in children predispose for chronic respiratory diseases later in life.
- In 2015, 10.4 million people developed tuberculosis and 1.4 million people died from it.
- The most common lethal neoplasm in the world is lung cancer, which kills 1.6 million people each year; and the numbers are growing.
- More than 100 million people suffer from sleep-disordered breathing.
- Millions live with pulmonary hypertension.
- More than 50 million people struggle with occupational lung diseases.
Unique solutions to make a real impact
Stethee + Amox-DT
To diagnose & treat
Paediatric Pneumonia
We aim to impact the 14.1% of deaths in under-fives caused by pneumonia by offering a complete and globally accessible diagnostic and treatment package.
Stethee
The advent of deep neural network learning has paved the way for diagnostic hardware and artificial intelligence to provide serious support to healthcare practitioners to better diagnose respiratory diseases faster, more accurately and more effectively.
Stethee is arguably the most Intelligent, Versatile, and Powerful Stethoscope ever created. This handheld device captures collective data over time helping to unlock patterns of disease that could not be captured by a traditional stethoscopes.
Amox-DT
Approved format for 1st line treatment of Community Acquired Pneumonia (CAP) in 2-59 month old children. The dispersible tablet format allows for improved compliance.
Driven to tackle the biggest problems with novel solutions and excellent partners
As part of our ongoing fight against this disease, we continue to explore novel, evidence-based products and concepts; working with like-minded inventors and partners to get the right treatments to the people in need, when they need them.
Currently, we are focusing on products in the following areas.
- Chronic Obstructive Pulmonary Disease (COPD)
- Upper and Lower Respiratory tract infections
- Asthma